The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Open accessPublished version of a preprint
Abstract
We previously piloted the concept of a Connectivity Map (CMap), whereby genes, drugs, and disease states are connected by virtue of common gene-expression signatures. Here, we report more than a 1,000-fold scale-up of the CMap as part of the NIH LINCS Consortium, made possible by a new, low-cost, high-throughput reduced representation expression profiling method that we term L1000. We show that L1000 is highly reproducible, comparable to RNA sequencing, and suitable for computational inference of the expression levels of 81% of non-measured transcripts. We further show that the expanded CMap can be used to discover mechanism of action of small molecules, functionally annotate genetic variants of disease genes, and inform clinical trials. The 1.3 million L1000 profiles described here, as well as tools for their analysis, are available at https://clue.io.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The magnitude of gene expression changes has been reported to correlate with functional impact (Wawer et al. 2014; Subramanian et al. 2017)”
From Murine single-cell RNA-seq reveals cell-identity- and tissue-specific trajectories of aging (2019) · cites this paper as Subramanian et al. 2017
Experimental — accuracy not yet measuredIn the citing paper
“many transcriptional states could be faithfully inferred from a subset of gene expression measurements32,33”
From Combinatorial single-cell CRISPR screens by direct guide RNA capture and targeted sequencing (2020) · cites this paper as [33]
In the citing paper
“Alternatively, gene panels such as the L1000 panel34 could be used (Extended Data Figure 3), which has been shown to capture the majority of information contained in the full transcriptome across a wide range of perturbations34.”
From Targeted Perturb-seq enables genome-scale genetic screens in single cells (2020) · cites this paper as [34]
In the citing paper
“Perturbation modelling is underpinned by systematic databases of biological response to treatment (e.g. Connectivity Map [2], L1000, DRUG-seq [3]) and leverages the significant potential of machine learning (ML) to make predictive models, e.g., molecular targets or IC50 values.”
From A mini-review on perturbation modelling across single-cell omic modalities (2024) · cites this paper as [2]
In the citing paper
“Of note, the LINCS consortium, and in particular the L1000 Connectivity Map resource, provides a catalog of postperturbation transcriptomics profiles for thousands of compounds, offering a global map of the phenotypic response landscape of the medicinal chemistry space.205”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [205]
In the citing paper
“Another caveat of our approach is the likely existence of null signatures corresponding to innocuous molecules with no actual bioactivity in a given CC data type38.”
From Bioactivity descriptors for uncharacterized chemical compounds (2021) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Self-citation(2008) · Journal of Machine Learning Research · Cited by 33,051
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Open Babel: An open chemical toolbox
O'Boyle, N. M., Banck, M. S., James, C. A. J., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011) · Journal of Cheminformatics · doi:10.1186/1758-2946-3-33 · Cited by 10,745
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
<tt>BLAT</tt> —The <tt>BLAST</tt> -Like Alignment Tool
Kent, W. J. (2002) · Genome Research · doi:10.1101/gr.229202 · Cited by 8,480
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Self-citationThe Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
The GTEx Consortium, Ardlie, K. G., Deluca, D. S., Segrè, A. V., Sullivan, T. J., Young, T. R., Gelfand, E. T., Trowbridge, C. A., Maller, J. B., Tukiainen, T., et al. (2015) · Science · doi:10.1126/science.1262110 · Cited by 5,062
Self-citationDefining a Cancer Dependency Map
Tsherniak, A., Vazquez, F., Montgomery, P. G., Weir, B. A., Kryukov, G., Cowley, G. S., Gill, S., Harrington, W. F., Pantel, S., Krill-Burger, J. M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.010 · Cited by 3,276
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Illumina Inc. (2007). BeadStudio Normalization Algorithms for Gene Expression Data (Illumina Technical Bulletin Pub. No.470-2007-005).
Cited by
Sorted by citations
Items 601–700 of 1,010
Chemical-induced gene expression ranking and its application to pancreatic cancer drug repurposing
Pham, T.-H., Qiu, Y., Liu, J., Zimmer, S., O’Neill, E. E., Xie, L., & Zhang, P. (2022) · Patterns · doi:10.1016/j.patter.2022.100441 · Cited by 39
Prediction of multi-relational drug–gene interaction via Dynamic hyperGraph Contrastive Learning
Wen, T., Liu, Y., Lin, X., Song, B., & Zeng, X. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad371 · Cited by 34
Chen, F., Wu, Y.-L., Cheng, C., Hsiao, Y., Chi, J.-Y., Hung, L., Chang, C., Lai, M., & Wang, J. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-023-00991-7 · Cited by 34
RNA Sequencing in Disease Diagnosis
Smail, C., & Montgomery, S. B. (2024) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-021623-121812 · Cited by 35
Repurposing drugs to treat l-DOPA-induced dyskinesia in Parkinson's disease
Johnston, T. H., Lacoste, A. M. B., Visanji, N. P., Lang, A. E., Fox, S. H., & Brotchie, J. M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.05.035 · Cited by 33
A survey of web resources and tools for the study of TCM network pharmacology
Zhao, J., Yang, J., Tian, S., & Zhang, W. (2019) · Quantitative Biology · doi:10.1007/s40484-019-0167-8 · Cited by 35
Extracellular Vesicles as Diagnostics and Therapeutics for Structural Epilepsies
Karttunen, J., Heiskanen, M., Lipponen, A., Poulsen, D. J., & Pitkänen, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061259 · Cited by 34
Perturbational Gene-Expression Signatures for Combinatorial Drug Discovery
Huang, C.-T., Hsieh, C.-H., Chung, Y.-H., Oyang, Y.-J., Huang, H., & Juan, H. (2019) · iScience · doi:10.1016/j.isci.2019.04.039 · Cited by 32
Li, H., Ericsson, M., Rabasha, B., Budnik, B., Chan, S. H., Freinkman, E., Lewis, C. A., Doench, J. G., Wagner, B. K., Garraway, L. A., et al. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.05.006 · Cited by 33
Self-citationA Functional Landscape of CKD Entities From Public Transcriptomic Data
Tajti, F., Kuppe, C., Antoranz, A., Ibrahim, M. M., Kim, H., Ceccarelli, F., Holland, C. H., Olauson, H., Floege, J., Alexopoulos, L. G., et al. (2019) · Kidney International Reports · doi:10.1016/j.ekir.2019.11.005 · Cited by 31
Computational discovery of therapeutic candidates for preventing preterm birth
Le, B. L., Iwatani, S., Wong, R. J., Stevenson, D. K., & Sirota, M. (2020) · JCI Insight · doi:10.1172/jci.insight.133761 · Cited by 34
Mamoshina, P., Bueno‐Orovio, A., & Rodríguez, B. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00639 · Cited by 34
Lymecycline reverses acquired EGFR-TKI resistance in non–small-cell lung cancer by targeting GRB2
Yang, C., Wu, J., Yan, H., Yang, C. Z., Wang, Y., Yang, Y., Deng, M., Che, X., Hou, K., Qu, X., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105007 · Cited by 33
Prediction of repurposed drugs for treating lung injury in COVID-19
He, B., & Garmire, L. X. (2020) · F1000Research · doi:10.12688/f1000research.23996.2 · Cited by 33
Feng, J., Zhang, H., & Li, F. (2021) · BMC Bioinformatics · doi:10.1186/s12859-020-03850-6 · Cited by 33
Trends in Deep Learning for Property-driven Drug Design
Born, J., & Manica, M. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210729115728 · Cited by 36
A systems‐level study reveals host‐targeted repurposable drugs against SARS‐CoV‐2 infection
Chen, F., Shi, Q., Pei, F., Vogt, A., Porritt, R. A., Garcia, G., Gomez, A. C., Cheng, M. H., Schurdak, M. E., Liu, B., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.202110239 · Cited by 31
Li, Y., Yang, L., Wang, Y., Deng, Z., Xu, S., Xie, H., Zhang, Y., & Li, J. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105971 · Cited by 33
Radovich, M., Solzak, J. P., Wang, C. J., Hancock, B. A., Badve, S., Althouse, S. K., Bray, S. M., Storniolo, A. M., Ballinger, T. J., Schneider, B. P., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-3078 · Cited by 33
Geevimaan, K., Guo, J.-Y., Shen, C., Jiang, J., Fann, C. S. J., Hwang, M., Shui, J., Lin, H.-T., Wang, M.-J. S., Shih, H.-C., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.883437 · Cited by 34
Zhu, J., Meng, H., Zhang, L., & Li, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04218-z · Cited by 33
Sustainable data and metadata management at the BD2K-LINCS Data Coordination and Integration Center
Stathias, V., Koleti, A., Vidović, D., Cooper, D. J., Jagodnik, K. M., Terryn, R., Forlin, M., Chung, C., Torre, D., Ayad, N. G., et al. (2018) · Scientific Data · doi:10.1038/sdata.2018.117 · Cited by 35
Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patientsPreprint
Aschenbrenner, A. C., Mouktaroudi, M., Krämer, B., Antonakos, N., Oestreich, M., Gkizeli, K., Nuesch-Germano, M., Saridaki, M., Bonaguro, L., Reusch, N., et al. (2020) · medRxiv · doi:10.1101/2020.07.07.20148395 · Cited by 33
Liu, G., Singha, M., Pu, L., Neupane, P., Feinstein, J., Wu, H., Ramanujam, J., & Bryliński, M. (2021) · Journal of Cheminformatics · doi:10.1186/s13321-021-00540-0 · Cited by 37
Schrörs, B., Hos, B. J., Yildiz, I., Löwer, M., Lang, F., Holtsträter, C., Becker, J., Vormehr, M., Şahin, U., OSSENDORP, F. A., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1102282 · Cited by 38
Transfer Learning with Kernel Methods
Radhakrishnan, A., Luyten, M. R., Prasad, N., & Uhler, C. (2023) · Nature Communications · doi:10.1038/s41467-023-41215-8 · Cited by 34
Personalized tumor combination therapy optimization using the single-cell transcriptome
Tang, C., Fu, S., Jin, X., Li, W., Xing, F., Duan, B., Cheng, X., Chen, X., Wang, S., Zhu, C., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01256-6 · Cited by 35
AI-empowered perturbation proteomics for complex biological systems
Qian, L., Sun, R., Aebersold, R. H., Bühlmann, P., Sander, C., & Guo, T. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100691 · Cited by 33
Pharmacogenomics and big genomic data: from lab to clinic and back again
Lavertu, A., McInnes, G., Daneshjou, R., Whirl‐Carrillo, M., Klein, T. E., & Altman, R. B. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy116 · Cited by 32
Translating GWAS Findings to Novel Therapeutic Targets for Coronary Artery Disease
Shu, L., Blencowe, M., & Yang, X. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00056 · Cited by 31
High-Throughput Gene Expression Profiles to Define Drug Similarity and Predict Compound Activity
Wolf, H. D., Cougnaud, L., Hoorde, K. V., Bondt, A. D., Wegner, J. K., Ceulemans, H., & Göhlmann, H. W. H. (2018) · Assay and Drug Development Technologies · doi:10.1089/adt.2018.845 · Cited by 34
Dubuis, S., Ortmayr, K., & Zampieri, M. (2018) · Communications Biology · doi:10.1038/s42003-018-0111-x · Cited by 35
An Overview of Computational Methods, Tools, Servers, and Databases for Drug Repurposing
Sarvagalla, S., Syed, S. B., & Coumar, M. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00025-0 · Cited by 32
Establishing cell painting in a smaller chemical biology lab – A report from the frontier
Svenningsen, E. B., & Poulsen, T. B. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.03.052 · Cited by 32
Zhang, Y., Zheng, Y., Fu, Y., & Wang, C. (2019) · Adipocyte · doi:10.1080/21623945.2019.1649578 · Cited by 32
EXP2SL: A Machine Learning Framework for Cell-Line-Specific Synthetic Lethality Prediction
Wan, F., Li, S., Tian, T., Lei, Y., Zhao, D. Y., & Zeng, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00112 · Cited by 33
Genomics-guided pre-clinical development of cancer therapies
Francies, H. E., McDermott, U., & Garnett, M. J. (2020) · Nature Cancer · doi:10.1038/s43018-020-0067-x · Cited by 32
Haberman, Y., Minar, P., Karns, R. A., Dexheimer, P. J., Ghandikota, S. K., Tegge, S. M., Shapiro, D., Shuler, B., Venkateswaran, S., Braun, T., et al. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa166 · Cited by 32
Molecular Footprints of the Immune Assault on Pancreatic Beta Cells in Type 1 Diabetes
Colli, M. L., Szymczak, F., & Eizirik, D. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.568446 · Cited by 33
A review of COVID-19 biomarkers and drug targets: resources and tools
Caruso, F. P., Scala, G., Cerulo, L., & Ceccarelli, M. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa328 · Cited by 35
Targeting RUNX1 in acute myeloid leukemia: preclinical innovations and therapeutic implications
Gonzales, F., Barthélémy, A., Peyrouze, P., Fenwarth, L., Preudhomme, C., Duployez, N., & Cheok, M. H.-C. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1915991 · Cited by 31
Drug repurposing strategies of relevance for Parkinson’s disease
Fletcher, E. J. R., Kaminski, T. W., Williams, G. H., & Duty, S. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.841 · Cited by 31
Computational biology approaches for mapping transcriptional regulatory networks
Saint‐André, V. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.08.028 · Cited by 34
Computational drug repositioning of atorvastatin for ulcerative colitis
Bai, L., Scott, M. K. D., Steinberg, E., Kalesinskas, L., Habtezion, A., Shah, N. H., & Khatri, P. (2021) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocab165 · Cited by 32
Xiao, M., Liang, X.-J., Yan, Z., Chen, J., Zhu, Y., Xie, Y., Li, Y., Li, X., Gao, Q., Feng, F., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.803962 · Cited by 33
Network-based stage-specific drug repurposing for Alzheimer’s disease
Savva, K., Zachariou, M., Bourdakou, M. M., Dietis, N., & Spyrou, G. M. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.03.013 · Cited by 32
Bioinformatics roadmap for therapy selection in cancer genomics
Jiménez‐Santos, M. J., García‐Martín, S., Torre, C. F., Domenico, T. D., Goméz-López, G., & Al‐Shahrour, F. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13286 · Cited by 35
Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning
Zhang, C., Shi, M., Kim, W., Arif, M., Klevstig, M., Li, X., Yang, H., Bayram, C., Bolat, İ., Tozlu, Ö. Ö., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104214 · Cited by 32
Editorial: Drug Repositioning: Current Advances and Future Perspectives
Nishimura, Y., & Hara, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01068 · Cited by 32
Hoagland, D. A., Clarke, D. J. B., Møller, R., Han, Y., Yang, L., Wojciechowicz, M. L., Lachmann, A., Oguntuyo, K. Y., Stevens, C. S., Lee, B., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.12.199687 · Cited by 31
Prediction of robust scientific facts from literature
Belikov, A. V., Rzhetsky, A., & Evans, J. (2022) · Nature Machine Intelligence · doi:10.1038/s42256-022-00474-8 · Cited by 30
PerturbNet predicts single-cell responses to unseen chemical and genetic perturbations
Yu, H., Qian, W., Song, Y., & Welch, J. D. (2025) · Molecular Systems Biology · doi:10.1038/s44320-025-00131-3 · Cited by 57
Ingebriktsen, L. M., Finne, K., Akslen, L. A., & Wik, E. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01953-w · Cited by 34
Metastatic pancreatic neuroendocrine tumors feature elevated T cell infiltration
Greenberg, J. A., Limberg, J. N., Verma, A., Kim, D., Chen, X. '., Lee, Y. J., Moore, M. D., Ullmann, T. M., Thiesmeyer, J. W., Loewenstein, Z., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.160130 · Cited by 31
Ding, X., Qin, J., Huang, F., Feng, F., & Luo, L. (2023) · Inflammation Research · doi:10.1007/s00011-023-01732-0 · Cited by 31
Kohlmeyer, J. L., Lingo, J. J., Kaemmer, C. A., Scherer, A., Warrier, A., Voigt, E. M., Garay, J. A. R., McGivney, G. R., Brockman, Q. R., Tang, A., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0749 · Cited by 35
Kim, S. Y., & Cheon, J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102446 · Cited by 33
Transcriptomic Data Mining and Repurposing for Computational Drug Discovery
Wang, Y., Yella, J., & Jegga, A. G. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8955-3_5 · Cited by 32
Chen, J., Hsieh, Y., Lo, H.-L., Li, A., Chou, C.-J., & Yang, P. (2019) · Biomolecules · doi:10.3390/biom9090467 · Cited by 31
Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy
Cheung, C. H. Y., Hsu, C., Tsuei, C.-Y., Kuo, T., Huang, C.-T., Hsu, W., Chung, Y.-H., Wu, H.-Y., Hsu, C., Huang, H., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2033-z · Cited by 31
Fabbri, C., Montgomery, S., Lewis, C. M., & Serretti, A. (2020) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000305 · Cited by 32
Gardiner, L., Carrieri, A. P., Wilshaw, J., Checkley, S., Pyzer‐Knapp, E. O., & Krishna, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-66481-0 · Cited by 32
Liu, J., Chen, X., Jiang, Y., & Cheng, W. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106735 · Cited by 31
Wright, G. E. B., Caron, N. S., Ng, B., Casal, L. L., Casazza, W., Xu, X., Ooi, J., Pouladi, M. A., Mostafavi, S., Ross, C. J., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa184 · Cited by 31
Significance Tests of Feature Relevance for a Black-Box Learner
Dai, B., Shen, X., & Pan, W. (2022) · IEEE Transactions on Neural Networks and Learning Systems · doi:10.1109/tnnls.2022.3185742 · Cited by 34
Cakir, A., Tuncer, M. E., Taymaz‐Nikerel, H., & Ulucan, Ö. (2021) · The Pharmacogenomics Journal · doi:10.1038/s41397-021-00246-4 · Cited by 30
Cui, Z., Sun, G., Bhandari, R., Lu, J., Zhang, M., Bhandari, R., Sun, F., Liu, Z., & Zhao, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.684322 · Cited by 31
Self-citationMadsen, R. R., Erickson, E. C., Rueda, O. M., Robin, X., Caldas, C., Toker, A., Semple, R. K., & Vanhaesebroeck, B. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009876 · Cited by 33
Wu, Y., Li, K., Li, Y., Sun, T., Liu, C., Dong, C., Zhao, T., Tang, D., Chen, X., Chen, X., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1201 · Cited by 31
Deep neural network prediction of genome-wide transcriptome signatures – beyond the Black-box
Magnusson, R., Tegner, J. N., & Gustafsson, M. (2022) · npj Systems Biology and Applications · doi:10.1038/s41540-022-00218-9 · Cited by 31
Pooled genetic screens with image‐based profiling
Walton, R. T., Singh, A. K., & Blainey, P. C. (2022) · Molecular Systems Biology · doi:10.15252/msb.202110768 · Cited by 29
Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis
Amadori, L., Calcagno, C., Fernandez, D. M., Koplev, S., Fernandez, N., Kaur, R., Mury, P., Khan, N. S., Sajja, S., Shamailova, R., et al. (2023) · Nature Cardiovascular Research · doi:10.1038/s44161-023-00278-y · Cited by 31
Harrill, J., Everett, L. J., Haggard, D. E., Bundy, J. L., Willis, C. M., Shah, I., Friedman, K. P., Basili, D., Middleton, A., & Judson, R. (2023) · Toxicology · doi:10.1016/j.tox.2023.153694 · Cited by 31
Accurate Drug Repositioning through Non-tissue-Specific Core Signatures from Cancer Transcriptomes
Chi, X., Ai, D., Shi, D., Suo, S., Chen, X., Yan, Y., Cao, Y., Zhang, R., Sun, N., Chen, W., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.031 · Cited by 31
Akıncı, E., Cha, M., Lin, L., Yeo, G. H. T., Hamilton, M. C., Donahue, C. J., Bermudez-Cabrera, H. C., Zanetti, L. C., Chen, M., Barkal, S. A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.27.270819 · Cited by 32
Boolean dynamic modeling of cancer signaling networks: Prognosis, progression, and therapeutics
Sherekar, S., & Viswanathan, G. A. (2021) · Computational and Systems Oncology · doi:10.1002/cso2.1017 · Cited by 31
CD74 as a prognostic and M1 macrophage infiltration marker in a comprehensive pan-cancer analysis
Li, R. Q., Yan, L., Zhang, L., Zhao, Y., & Lian, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-58899-7 · Cited by 34
Phenotypic complexities of rare heterozygous neurexin-1 deletions
Fernando, M. B., Fan, Y., Zhang, Y., Tokolyi, A., Murphy, A., Kammourh, S., Deans, P. J. M., Ghorbani, S., Onatzevitch, R., Pero, A., et al. (2025) · Nature · doi:10.1038/s41586-025-08864-9 · Cited by 30
A Systems Toxicology Approach for the Prediction of Kidney Toxicity and Its Mechanisms In Vitro
Ramm, S., Todorov, P. V., Chandrasekaran, V., Dohlman, A. B., Monteiro, M. B., Pavkovic, M., Muhlich, J. L., Shankaran, H., Chen, W. W., Mettetal, J. T., et al. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz021 · Cited by 33
Park, J. G., Mok, J. S., Han, Y. I., Park, T. S., Kang, K. W., Choi, C. S., Park, J., & Park, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-40322-1 · Cited by 30
Litten, R. Z., Falk, D. E., Ryan, M. L., Fertig, J. B., & Leggio, L. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14233 · Cited by 31
Identification of longevity compounds with minimized probabilities of side effects
Janssens, G. E., & Houtkooper, R. H. (2020) · Biogerontology · doi:10.1007/s10522-020-09887-7 · Cited by 28
Experimental Models as Refined Translational Tools for Breast Cancer Research
Costa, E., Ferreira-Gonçalves, T., Chasqueira, G., Cabrita, A., Figueiredo, I. V., & Reis, C. P. (2020) · Scientia Pharmaceutica · doi:10.3390/scipharm88030032 · Cited by 30
Davies, R. G., Liu, L., Sheng, T., Tuano, N., Chaturvedi, R., Huang, K. K., Itman, C., Mandoli, A., Qamra, A., Hu, C., et al. (2021) · Genome biology · doi:10.1186/s13059-021-02266-6 · Cited by 30
Beheshtizadeh, N., Asgari, Y., Nasiri, N., Farzin, A., Ghorbani, M., Lotfibakhshaiesh, N., & Azami, M. (2021) · Tissue and Cell · doi:10.1016/j.tice.2021.101553 · Cited by 30
van Harten, A. M., & Brakenhoff, R. H. (2021) · Cancers · doi:10.3390/cancers13112774 · Cited by 33
Xu, F., Tong, M., Tong, C. S. W., Chan, B. K. C., Chu, H. Y., Wong, T. L., Fong, J. H. C., Cheung, M. S. H., Mak, K. H.-M., Pardeshi, L. A., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1017 · Cited by 30
Yoo, S., Sinha, A., Yang, D., Altorki, N. K., Tandon, R., Wang, W., Chavez, D., Lee, E., Patel, A. S., Sato, T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29230-7 · Cited by 30
Repurposing Drugs via Network Analysis: Opportunities for Psychiatric Disorders
Truong, T. T. T., Panizzutti, B., Kim, J. H., & Walder, K. R. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071464 · Cited by 33
Su, J., Peng, J., Wang, L., Xie, H., Zhou, Y., Chen, H., Shi, Y., Guo, Y. H., Zheng, Y., Guo, Y., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1206154 · Cited by 30
Gex2SGen: Designing Drug-like Molecules from Desired Gene Expression Signatures
Das, D., Chakrabarty, B., Srinivasan, R., & Roy, A. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c01301 · Cited by 29
Zhang, Y., Wang, Y., Wu, C., Zhan, L., Wang, A., Cheng, C., Zhao, J., Zhang, W., Chen, J., & Li, P. (2024) · BMC Bioinformatics · doi:10.1186/s12859-024-05976-3 · Cited by 29
Chmelyuk, N. S., Kordyukova, M., Sorokina, M. A., Sinyavskiy, S., Meshcheryakova, V., Belousov, V. V., & Abakumova, T. O. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052084 · Cited by 29
A versatile information retrieval framework for evaluating profile strength and similarity
Kalinin, A. A., Arévalo, J., Serrano, E., Vulliard, L., Tsang, H., Bornholdt, M., Muñoz, A. F., Sivagurunathan, S., Rajwa, B. P., Carpenter, A. E., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60306-2 · Cited by 29
Centralized scientific communities are less likely to generate replicable results
Danchev, V., Rzhetsky, A., & Evans, J. A. (2019) · eLife · doi:10.7554/elife.43094 · Cited by 28
Iyaswamy, A., Krishnamoorthi, S., Liu, Y. W., Song, J., Kammala, A. K., Sreenivasmurthy, S. G., Malampati, S., Tong, B. C., Selvarasu, K., Cheung, K., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.584770 · Cited by 29
Chemocentric Informatics Analysis: Dexamethasone Versus Combination Therapy for COVID-19
Hajjo, R., Sabbah, D. A., & Bardaweel, S. K. (2020) · ACS Omega · doi:10.1021/acsomega.0c03597 · Cited by 29
Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics
Liu, D., Liu, J., Liang, S., Meng, X., Greenbaum, J., Xiao, H., Tan, L., & Deng, H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13040545 · Cited by 32
Dannenmann, B., Klimiankou, M., Oswald, B., Solovyeva, A., Mardan, J., Nasri, M., Ritter, M. U., Zahabi, A., Arreba-Tutusaus, P., Mir, P., et al. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.03.023 · Cited by 29
Jeon, J., Kang, S., & Kim, H. U. (2021) · Natural Product Reports · doi:10.1039/d1np00016k · Cited by 29
Metadata
- Authors
- Subramanian, A., Narayan, R., Corsello, S. M., Peck, D. D., Natoli, T. E., Lu, X., Gould, J., Davis, J. F., Tubelli, A. A., Asiedu, J. K., Lahr, D. L., Hirschman, J. E., Liu, Z., Donahue, M., Julian, B., Khan, M., Wadden, D., Smith, I. C., Lam, D., Liberzon, A., Toder, C., Bagul, M., Orzechowski, M., Enache, O. M., Piccioni, F., Johnson, S. A., Lyons, N. J., Berger, A. H., Shamji, A. F., Brooks, A. N., Vrcic, A., Flynn, C., Rosains, J., Takeda, D. Y., Hu, R., Davison, D., Lamb, J., Ardlie, K., Hogstrom, L., Greenside, P., Gray, N. S., Clemons, P. A., Silver, S., Wu, X., Zhao, W.-N., Read-Button, W., Wu, X., Haggarty, S. J., Ronco, L. V., Boehm, J. S., Schreiber, S. L., Doench, J. G., Bittker, J. A., Root, D. E., Wong, B., & Golub, T. R.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Golub, Todd R.
- ORCID
- Subramanian, Aravind
- Corsello, Steven M.
- Gould, Joshua
- Tubelli, Andrew A.
- Lahr, David L.
- Hirschman, Jodi E.
- Liu, Zihan
- Khan, Mariya
- Smith, Ian C.
- Orzechowski, Marek
- Enache, Oana M.
- Piccioni, Federica
- Johnson, Sarah A.
- Berger, Alice H.
- Brooks, Angela N.
- Vrcic, Anita
- Takeda, David Y.
- Ardlie, Kristin
- Gray, Nathanael S.
- Clemons, Paul A.
- Silver, Serena
- Wu, Xiaoyun
- Zhao, Wen-Ning
- Haggarty, Stephen J.
- Ronco, Lucienne V.
- Boehm, Jesse S.
- Schreiber, Stuart L.
- Doench, John G.
- Bittker, Joshua A.
- Root, David E.
- Golub, Todd R.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 171
- Issue
- 6
- Pages
- 1437-1452.e17
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC5990023
- OpenAlex
- W2612467560
- Cited by
- 3,515
- References
- 73
- Citations by year
- 2026: 436 · 2025: 479 · 2024: 493 · 2023: 458 · 2022: 507 · 2021: 421 · 2020: 320 · 2019: 261 · 2018: 122 · 2017: 12
- FWCI
- 80.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- NIH (U54HG006093, U54HL127366, U01HG008699, CA009172, TR001100)
- Conquer Cancer Foundation of ASCO Young
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- Connectivity Map, L1000, gene expression signatures, functional annotation of genetic variants, reproducibility, clinical trial design
- MeSH terms
- Pharmaceutical Preparations, Humans, Neoplasms, Organ Specificity, Sequence Analysis, RNA, Drug Resistance, Neoplasm, Gene Expression Profiling, Cell Line, Tumor, Small Molecule Libraries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
